Pharmacological and behavioral profile of N-(4-fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl) carbamide (2R, 3R)-dihydroxybutanedioate (2:1) (ACP-103), a novel 5-hydroxytryptamine2A receptor inverse agonist

Kimberly E. Vanover; David M. Weiner; Malath Makhay; Isaac Veinbergs; Luis R. Gardell; Jelveh Lameh; Andria L. del Tredici; Fabrice Piu; Hans H. Schiffer; Thomas R. Ott; Ethan S. Burstein; Allan K. Uldam; Mikkel Boas Thygesen; Nathalie Schlienger; Carl Magnus Andersson; Thomas Y. Son; Scott C. Harvey; Susan B. Powell; Mark A. Geyer; Bo-Ragner Tolf; Mark R. Brann; Robert E. Davis

doi:10.1124/jpet.105.097006

Pharmacological and behavioral profile of N-(4-fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl) carbamide (2R, 3R)-dihydroxybutanedioate (2:1) (ACP-103), a novel 5-hydroxytryptamine_2A receptor inverse agonist

Kimberly E. Vanover, David M. Weiner, Malath Makhay, Isaac Veinbergs, Luis R. Gardell, Jelveh Lameh, Andria L. del Tredici, Fabrice Piu, Hans H. Schiffer, Thomas R. Ott, Ethan S. Burstein, Allan K. Uldam, Mikkel Boas Thygesen, Nathalie Schlienger, Carl Magnus Andersson, Thomas Y. Son, Scott C. Harvey, Susan B. Powell, Mark A. Geyer, Bo-Ragner TolfMark R. Brann, Robert E. Davis

124 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Journal of Pharmacology and Experimental Therapeutics
Vol/bind	317
Udgave nummer	2
Sider (fra-til)	910-918
Antal sider	9
ISSN	0022-3565
DOI	https://doi.org/10.1124/jpet.105.097006
Status	Udgivet - 2006
Udgivet eksternt	Ja

Adgang til dokumentet

10.1124/jpet.105.097006

Citationsformater

Vanover, K. E., Weiner, D. M., Makhay, M., Veinbergs, I., Gardell, L. R., Lameh, J., del Tredici, A. L., Piu, F., Schiffer, H. H., Ott, T. R., Burstein, E. S., Uldam, A. K., Thygesen, M. B., Schlienger, N., Andersson, C. M., Son, T. Y., Harvey, S. C., Powell, S. B., Geyer, M. A., ... Davis, R. E. (2006). Pharmacological and behavioral profile of N-(4-fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl) carbamide (2R, 3R)-dihydroxybutanedioate (2:1) (ACP-103), a novel 5-hydroxytryptamine_2A receptor inverse agonist. Journal of Pharmacology and Experimental Therapeutics, 317(2), 910-918. https://doi.org/10.1124/jpet.105.097006

Pharmacological and behavioral profile of N-(4-fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl) carbamide (2R, 3R)-dihydroxybutanedioate (2:1) (ACP-103), a novel 5-hydroxytryptamine_2A receptor inverse agonist. / Vanover, Kimberly E.; Weiner, David M.; Makhay, Malath et al.
I: Journal of Pharmacology and Experimental Therapeutics, Bind 317, Nr. 2, 2006, s. 910-918.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Vanover, KE, Weiner, DM, Makhay, M, Veinbergs, I, Gardell, LR, Lameh, J, del Tredici, AL, Piu, F, Schiffer, HH, Ott, TR, Burstein, ES, Uldam, AK, Thygesen, MB, Schlienger, N, Andersson, CM, Son, TY, Harvey, SC, Powell, SB, Geyer, MA, Tolf, B-R, Brann, MR & Davis, RE 2006, 'Pharmacological and behavioral profile of N-(4-fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl) carbamide (2R, 3R)-dihydroxybutanedioate (2:1) (ACP-103), a novel 5-hydroxytryptamine_2A receptor inverse agonist', Journal of Pharmacology and Experimental Therapeutics, bind 317, nr. 2, s. 910-918. https://doi.org/10.1124/jpet.105.097006

Vanover KE, Weiner DM, Makhay M, Veinbergs I, Gardell LR, Lameh J et al. Pharmacological and behavioral profile of N-(4-fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl) carbamide (2R, 3R)-dihydroxybutanedioate (2:1) (ACP-103), a novel 5-hydroxytryptamine_2A receptor inverse agonist. Journal of Pharmacology and Experimental Therapeutics. 2006;317(2):910-918. doi: 10.1124/jpet.105.097006

Vanover, Kimberly E. ; Weiner, David M. ; Makhay, Malath et al. / Pharmacological and behavioral profile of N-(4-fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl) carbamide (2R, 3R)-dihydroxybutanedioate (2:1) (ACP-103), a novel 5-hydroxytryptamine_2A receptor inverse agonist. I: Journal of Pharmacology and Experimental Therapeutics. 2006 ; Bind 317, Nr. 2. s. 910-918.

@article{70c843a86fac425ca13f71a8005e353f,

title = "Pharmacological and behavioral profile of N-(4-fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl) carbamide (2R, 3R)-dihydroxybutanedioate (2:1) (ACP-103), a novel 5-hydroxytryptamine2A receptor inverse agonist",

author = "Vanover, {Kimberly E.} and Weiner, {David M.} and Malath Makhay and Isaac Veinbergs and Gardell, {Luis R.} and Jelveh Lameh and {del Tredici}, {Andria L.} and Fabrice Piu and Schiffer, {Hans H.} and Ott, {Thomas R.} and Burstein, {Ethan S.} and Uldam, {Allan K.} and Thygesen, {Mikkel Boas} and Nathalie Schlienger and Andersson, {Carl Magnus} and Son, {Thomas Y.} and Harvey, {Scott C.} and Powell, {Susan B.} and Geyer, {Mark A.} and Bo-Ragner Tolf and Brann, {Mark R.} and Davis, {Robert E.}",

year = "2006",

doi = "10.1124/jpet.105.097006",

language = "English",

volume = "317",

pages = "910--918",

journal = "Journal of Pharmacology and Experimental Therapeutics",

issn = "0022-3565",

publisher = "American Society for Pharmacology and Experimental Therapeutics",

number = "2",

}

TY - JOUR

T1 - Pharmacological and behavioral profile of N-(4-fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl) carbamide (2R, 3R)-dihydroxybutanedioate (2:1) (ACP-103), a novel 5-hydroxytryptamine2A receptor inverse agonist

AU - Vanover, Kimberly E.

AU - Weiner, David M.

AU - Makhay, Malath

AU - Veinbergs, Isaac

AU - Gardell, Luis R.

AU - Lameh, Jelveh

AU - del Tredici, Andria L.

AU - Piu, Fabrice

AU - Schiffer, Hans H.

AU - Ott, Thomas R.

AU - Burstein, Ethan S.

AU - Uldam, Allan K.

AU - Thygesen, Mikkel Boas

AU - Schlienger, Nathalie

AU - Andersson, Carl Magnus

AU - Son, Thomas Y.

AU - Harvey, Scott C.

AU - Powell, Susan B.

AU - Geyer, Mark A.

AU - Tolf, Bo-Ragner

AU - Brann, Mark R.

AU - Davis, Robert E.

PY - 2006

Y1 - 2006

U2 - 10.1124/jpet.105.097006

DO - 10.1124/jpet.105.097006

M3 - Journal article

C2 - 16469866

SN - 0022-3565

VL - 317

SP - 910

EP - 918

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

IS - 2

ER -